Started: 1/2012
Study Name: A 6-Month Safety And Benefit Study Of Inhaled xxx Combination Versus Inhaled xxx In The Treatment Of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma”
Indication: Asthma
Principal Investigator: Brad Brabec
Started: 1/2012
Study Name: A 6-Month Safety And Benefit Study Of Inhaled xxx Combination Versus Inhaled xxx In The Treatment Of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma”
Indication: Asthma
Principal Investigator: Brad Brabec
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a multivalent…
A Phase 3, study to evaluate the safety, tolerability, and immunogenicity of…